Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse (Q45174166)

10 December 2017

title

Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse (English)

1 reference

10 December 2017

G Kuriya

1

1 reference

10 December 2017

T Uchida

2

1 reference

10 December 2017

S Akazawa

3

1 reference

10 December 2017

M Kobayashi

4

1 reference

10 December 2017

K Nakamura

5

1 reference

10 December 2017

T Satoh

6

1 reference

10 December 2017

I Horie

7

1 reference

10 December 2017

E Kawasaki

8

1 reference

10 December 2017

H Yamasaki

9

1 reference

10 December 2017

L Yu

10

1 reference

10 December 2017

Y Iwakura

11

1 reference

10 December 2017

H Sasaki

12

1 reference

10 December 2017

Y Nagayama

13

1 reference

10 December 2017

A Kawakami

14

1 reference

10 December 2017

N Abiru

15

1 reference

10 December 2017

publication date

23 May 2013

1 reference

10 December 2017

1 reference

10 December 2017

volume

56

1 reference

10 December 2017

issue

8

1 reference

10 December 2017

page(s)

1773-1780

1 reference

Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Plasticity of CD4 T cell lineage differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Late developmental plasticity in the T helper 17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Heterogeneity and plasticity of T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

IL-17 immunity in human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

Cutting Edge: Increased IL-17-Secreting T Cells in Children with New-Onset Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00125-013-2935-8

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

12 December 2020

IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes

1 reference

12 December 2020

IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.

1 reference

12 December 2020

Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide

1 reference

12 December 2020

Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice

1 reference

12 December 2020

Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning

1 reference

12 December 2020

Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice

1 reference

12 December 2020

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

12 December 2020

Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice

1 reference

12 December 2020

Diabetogenic T-cell clones

1 reference

12 December 2020

T Helper Type 17 Immune Response Plays an Indispensable Role for Development of Iodine-Induced Autoimmune Thyroiditis in Nonobese Diabetic-H2h4Mice

1 reference

12 December 2020

Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide

1 reference

12 December 2020

Prevention of type I diabetes in NOD mice by adjuvant immunotherapy

1 reference

12 December 2020

Both CD4 and CD8 T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction

1 reference

12 December 2020

10.1007/S00125-013-2935-8

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1001203695

0 references

1 reference